Oppenheimer Maintains Outperform on CEVA, Lowers Price Target to $38

Benzinga Newsdesk www.benzinga.com Negative 94.6%

Neg 94.6% Neu 0% Pos 0%

Oppenheimer analyst Martin Yang maintains CEVA (NASDAQ:CEVA) with a Outperform and lowers the price target from $42 to $38.